Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 3Ovarian Neoplasms 2Neoplasms 2Recurrence 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Liver Neoplasms 1Intraoral Tumor 1Esophageal Neoplasms 1Disease Progression 1Chalazion 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Brain Neoplasms 1Brain Edema 1

Interventions

Cisplatin 12pembrolizumab 11Magnetic Resonance Spectroscopy 11Specimen Handling 10Paclitaxel 6Platinum 5Cyclophosphamide 51,2-diaminocyclohexaneplatinum II citrate 5fludarabine 4durvalumab 4cemiplimab 4Radiotherapy, Intensity-Modulated 4Radiotherapy 3Pemetrexed 3Oxaliplatin 3Nivolumab 3Fluorouracil 3Cetuximab 3Carboplatin 3Biopsy 3poly ICLC 2fludarabine phosphate 2cabozantinib 2atezolizumab 2Radiation 2Ipilimumab 2Interviews as Topic 2Heavy Ion Radiotherapy 2Gemcitabine 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma × Sevoflurane × Clear all
NCT04475705 2022-03-16

Propofol vs Sevo for Paediatric Tumor Surgery

Hong Kong Children's Hospital

Phase 4 Recruiting
100 enrolled

Carcinoma, Neoplastic Cells, Circulating, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡